Helen Sabzevari Insider Profile
4 Followers
Helen Sabzevari, President & CEO at Precigen, holds 3.77M shares in Precigen (Ticker: PGEN), holds ― shares in Kinnate Biopharma (Ticker: KNTE). Most recently, Helen Sabzevari Sold ― shares of Precigen on Jun 01, 2026 for an estimated value of $519.93K.
Helen Sabzevari has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Helen Sabzevari's holdings
Insider Roles
President & CEO
Roles that Helen Sabzevari holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Helen Sabzevari
Helen Sabzevari's Trading History
Precigen
Jun 01, 2026
President & CEO
Informative Sell
519.93K
$16.36M
Kinnate Biopharma
―
―
―
―
List of latest transactions for each holding click on a transaction to see Helen Sabzevari's performance on stock
You May Also Like
Helen Sabzevari insider profile FAQ
What is the percentage of profitable transactions made by Helen Sabzevari?
The percentage of profitable transactions made by Helen Sabzevari is ―.
What is the average return per transaction made by Helen Sabzevari?
The average return per transaction made by Helen Sabzevari is ―.
What stocks does Helen Sabzevari hold?
Helen Sabzevari holds: PGEN, KNTE stocks.
What was Helen Sabzevari’s latest transaction?
Helen Sabzevari latest transaction was an Informative Sell of $519.93K.
What was Helen Sabzevari's most profitable transaction?
Helen Sabzevari’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Helen Sabzevari's role in Precigen?
Helen Sabzevari's role in Precigen is President & CEO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.